Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 24 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2001In vivo perturbation of rat hepatocyte canalicular membrane function by diclofenacSallustio, B.; Holbrook, F.
2004A new simple diagnostic assay for the identification of the major CYP2D6 genotypes by DNA sequencing analysisJames, H.; Coller, J.; Gillis, D.; Bahnisch, J.; Sallustio, B.; Somogyi, A.
2003Relationship between CYP2D6 genotype and plasma OH-perhexiline/perhexiline concentration ratio in angina patients.Sallustio, B.; Davies, B.; Coller, J.; James, H.; Gillis, D.; Somogyi, A.
2000Hepatic disposition of the acyl glucoronide 1-O-gemfibrozil--D-glucoronide: Effects of clofibric acid, acetaminophen, and acetaminophen glucuronideSabordo, L.; Sallustio, B.; Evans, A.; Nation, R.
2007Carboxylic acid drug-induced DNA nicking in HEK293 cells expressing human UDP-glucuronosyltransferases: Role of acyl glucuronide metabolites and glycation pathwaysSouthwood, H.; DeGraaf, Y.; MacKenzie, P.; Miners, J.; Burcham, P.; Sallustio, B.
2004Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7Toutsikos, P.; Miners, J.; Stapleton, A.; Thomas, A.; Sallustio, B.; Knights, K.
2005Validation of a high-performance liquid chromatography method for the measurement of mycophenolic acid and its glucuronide metabolites in plasmaWestley, I.; Sallustio, B.; Morris, R.
2008Steady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolizers administered Rac-perhexilineDavies, B.; Herbert, M.; Coller, J.; Somogyi, A.; Milne, R.; Sallustio, B.
2005The influence of CYP2D6 genotype on trough plasma perhexiline and cis-OH-perhexiline concentrations following a standard loading regimen in patients with myocardial ischaemiaDavies, B.; Coller, J.; James, H.; Somogyi, A.; Horowitz, J.; Sallustio, B.
2007Effect of CYP2D6 metabolizer status on the disposition of the (+) and (-) enantiomers of perhexiline in patients with myocardial ischaemiaInglis, S.; Herbert, M.; Davies, B.; Coller, J.; James, H.; Horowitz, J.; Morris, R.; Milne, R.; Somogyi, A.; Sallustio, B.